Vericel's Series F - II Round

Vericel raised a round of funding on July 01, 1996.

Vericel, formerly Aastrom Biosciences, develops, manufactures, and markets expanded autologous cell therapies for the treatment of patients with serious diseases and conditions. The company markets tw…

Articles about Vericel's Series F - II Round: